Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

GE to buy Abbott’s in vitro diag units for $8.13 billion in cash

Jan. 25, 2007

By Amanda Pedersen

Deals roundup: Vision-Sciences will sell certain ENT assets for up to $34 million

Jan. 25, 2007

By Amanda Pedersen

Zeiss gets fast FDA clearance for its Visumax laser system

Jan. 24, 2007

By Amanda Pedersen

Changes in market push GE to buy Abbott’s lab diagnostics

Jan. 22, 2007

By Amanda Pedersen

Deals roundup: Iridex closes Laserscope deal for $26M and 214,000 shares

Jan. 19, 2007

By Amanda Pedersen

Onex buys Kodak’s Health Group in deal worth up to $2.55 billion

Jan. 18, 2007

By Amanda Pedersen

Vision-Sciences will sell certain ENT assets for up to $34 million

Jan. 18, 2007

By Amanda Pedersen

PMA opens ‘new ballgame’ for AngioScore in U.S. CAD market

Jan. 12, 2007

By Amanda Pedersen

Onex buys Kodak’s Health Group in deal worth up to $2.55 billion

Jan. 11, 2007

By Amanda Pedersen

NovaVision in $20M in Series C funding to back VRT marketing

Jan. 10, 2007

By Amanda Pedersen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...